Table 2.
Initially ID-NAT-reactive tissue donorsa
Tissue | Specimen type | Ultrio Elite | Ultrio | dHIV | dHCV | dHBV | HIV | HCV | HBsAg | Anti | Anti-HBs | Anti-HBc |
---|---|---|---|---|---|---|---|---|---|---|---|---|
donor # | Elite 2 | Ag/Ab | Ab | HBc | IU/l | IgM | ||||||
4 | plasma | + (1:5) | ND | ND | ND | + (1:10)** | – | – | – | + | 32 | – |
5 | serum | + | ND | ND | ND | + (1:4) | – | – | – | + | 181 | – |
6 | plasma (cadaveric) | + | ND | – | – | + | – | – | + | + | – | – |
7 | serum | +(1:2) | ND | ND | ND | ND | – | – | + | + | ND | – |
8 | plasma (cadaveric) | + | + | ND | ND | – (1:3) | – | – | – | + | 124 | – |
9 | plasma | + | ND | – | – | – (1:2) | – | – | – | + | – | – |
10 | serum (cadaveric) | + (serum) | +*** | – | + | – | – | + | – | – | ND | ND |
11 | plasma (cadaveric) | + | ND | ND | + (1:4) | ND | ND | +* | ND | ND | ND | ND |
12 | plasma | +(1:3) | –(1:3) | ND | ND | ND | – | – | – | – | ND | ND |
Also positive for HCV antigen.
1:10 dilution not validated.
Additional plasma sample tested.
Several specimens had to be diluted prior to testing due to insufficient volume, dilution factors are indicated in brackets. In donor #11, serological screening was performed in another laboratory, merely HCV serology and ID-NAT was requested.
dHIV, dHCV and dHBV = Discriminatory tests for HIV-1/2, HCV and HBV, respectively (tests provided with the Ultrio Elite Kit); ND = not done.